Biofrontera (BFRI) Gross Profit Growth (1y) (2021 - 2026)
Biofrontera (BFRI) Gross Profit Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.43% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -8.36% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.56% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -3.83% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 9.27% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 38.19% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 11.92% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn | 50.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.17% |
| Dec 31, 2025 | 93.35% |
| Sep 30, 2025 | 19.54% |
| Jun 30, 2025 | 82.67% |
| Mar 31, 2025 | 40.15% |
| Dec 31, 2024 | -39.02% |
| Sep 30, 2024 | -53.02% |
| Jun 30, 2024 | 13.69% |
| Mar 31, 2024 | -9.32% |
| Dec 31, 2023 | 263.03% |
| Sep 30, 2023 | 108.36% |
| Jun 30, 2023 | -28.55% |
| Mar 31, 2023 | -56.29% |
| Dec 31, 2022 | 51.31% |
| Sep 30, 2022 | -1.61% |
| Jun 30, 2022 | -24.74% |
| Mar 31, 2022 | 109.04% |
| Sep 30, 2021 | 52.99% |